Cost-utility of repeated screening for Chlamydia trachomatis.

Cost-utility of repeated screening for Chlamydia trachomatis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cost-utility of repeated screening for Chlamydia trachomatis. Abstract Text:

Robin de Vries,Jan E A M van Bergen,Lolkje T W de Jong-van den Berg,Maarten J Postma, ,Robin de Vries,Jan E A M van Bergen,Lolkje T W de Jong-van den Berg,Maarten J Postma, ,

Objective: To estimate the cost-effectiveness of repeated screening for chlamydia trachomatis at various time intervals compared to one-off screening of Dutch young adults. Methods: We used a dynamic model to fully take the spread of the disease over time in the population into account, with data being used gathered within the context of a recently performed pilot study in The Netherlands. The screening frequencies analyzed were: every year, every 2 years, every 5 years, and every 10 years. The strategies were compared in terms of incremental cost-effectiveness, expressed as the net costs per quality-adjusted life-year (QALY). Results: For all interval strategies, with the exception of screening every year, incremental cost-effectiveness stays below the informal Dutch threshold of euro20,000 per QALY. Conclusion: From a health-economic point of view, for the Dutch situation, we estimated screening every 2 years as the optimal strategy among the options investigated.

Cost-utility of repeated screening for Chlamydia trachomatis. Publishing Authors By Initials

R de Vries,JE van Bergen,LT de Jong-van den Berg,MJ Postma, ,R de Vries,JE van Bergen,LT de Jong-van den Berg,MJ Postma, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cost-utility of repeated screening for Chlamydia trachomatis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Value in health : the journal of the International

VOLUME: 11

Page Numbers: 272-4

Journal Abbreviation:

ISSN: 1524-4733

DAY: 2

MONTH: 04

YEAR: 2008

Cost-utility of repeated screening for Chlamydia trachomatis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100883818

Cost-utility of repeated screening for Chlamydia trachomatis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cost-utility of repeated screening for Chlamydia trachomatis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cost-utility of repeated screening for Chlamydia trachomatis.

AFFILIATION: Groningen University Institute for Drug Exploration/University of Groningen Research Institute of Pharmacy, Groningen, The Netherlands.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Value Health

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cost-utility of repeated screening for Chlamydia trachomatis Related Publications

• A pertrochanteric fracture in an adolescent treated for an osteogenic sarcoma of the shaft of the femur with chemotherapy, tumour resection and endoprosthesis.
• Ambulatory pH monitoring methodology.
• Categorical and coordinate spatial representations within object-location memory.
• Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
• Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands.
• Cost-utility of repeated screening for Chlamydia trachomatis.
• Delay improves performance on a haptic spatial matching task.
• Economic evaluation of folic acid food fortification in The Netherlands.
• Elucidating empowerment in El Proyecto Bienestar (the Well-Being Project).
• Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions.
• Gastric asthma: a pathophysiological entity?
• Gender differences in asthma development and progression.
• Gender differences in memory for objects and their locations: A study on automatic versus controlled encoding and retrieval contexts.
• Inflated impact factors? The true impact of evolutionary papers in non-evolutionary journals.
• Interruption from irrelevant auditory and visual onsets even when attention is in a focused state.
• Late effects in adult survivors of childhood cancer: the need for life-long follow-up.
• Memory transfer for emotionally valenced words between identities in dissociative identity disorder.
• Multisensory integration affects ERP components elicited by exogenous cues.
• Multisensory integration mechanisms in haptic space perception.
• Neural correlates of locative prepositions.
• Protein production by Escherichia coli wild-type and DeltaptsG mutant strains with IPTG induction at the onset.
• Screening tools to prioritize routine dental care in an institutional environment.
• Selective impairments in spatial memory after ischaemic stroke.
• Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study.
• Spatial attention triggered by unimodal, crossmodal, and bimodal exogenous cues: a comparison of reflexive orienting mechanisms.
• Spatial working memory and contextual cueing in patients with Korsakoff amnesia.
• The Center for Bio-Pharmaceutical Sciences: scope and perspectives.
• The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach.
• Transnasal esophagoscopy.
• [Not Available.]